logo

Regencell Bioscience Holdings Ltd (RGC) Stock: 52-Week Performance Insights and Trading Volume

TOST Stock

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Regencell Bioscience Holdings Ltd’s current trading price is -70.10% away from its 52-week high, while its distance from the 52-week low is 220.13%. The stock’s price range for this period has been between $3.03 and $32.44 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 6.65 million for the day, a number notably higher than the average daily volume of 17530.0 over the last three months.

In terms of market performance, Regencell Bioscience Holdings Ltd had a fairly even. The highest value for the stock in the past year was $32.44 on 07/23/24, and the lowest value was recorded at $3.03 on 07/22/24.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Regencell Bioscience Holdings Ltd (RGC) has experienced a quarterly rise of 65.53% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 126.22M and boasts a workforce of 12 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 5.17, with a change in price of +5.58. Similarly, Regencell Bioscience Holdings Ltd recorded 96,560 in trading volume during the last 100 days, posting a change of +111.60%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for RGC stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.00.

RGC Stock Stochastic Average

As of today, Regencell Bioscience Holdings Ltd’s raw stochastic average for the last 50 days stands at 95.40%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 95.40%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 53.81% and 39.29%, respectively.

RGC Stock Price Performance Analysis

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. The metric has seen a significant gain of 96.36% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 53.72%. Over the past 30 days, the price of RGC has fallen by 159.71%. And in the last five days, it has surged by 129.75%.

Most Popular